Trius amends IPO

Trius Therapeutics Inc. (San Diego, Calif.) amended its IPO and hopes to sell 6 million shares at $12-$14. A $13 price would raise $78 million and value the company at $216.3 million. In November, Trius filed to raise up to $86.3 million in an IPO underwritten by Credit Suisse; Piper Jaffray; Canaccord; and JMP Securities. ...